Rx Medicare

The World Health Organization (WHO) urged pharmaceutical companies to donate at least 10 per cent of their H1N1 pandemic swine flu vaccine to poor countries, or at least offer them lower prices, to ensure that they don’t get left out as it is likely that demand will outstrip capacity to supply in the months ahead. Six out of 30 major drug companies have agreed to do so.

Read More…

Related Posts

• FDA Recommends H1N1 For Inclusion In Next Year’s Flu Vaccine
• SciClone And Sigma-Tau Announce Additional Positive Results In Clinical Study Examining ZADAXIN’s Ability To Enhance Response To H1N1 Vaccine
• Bharat Biotech Begins Phase I Clinical Trials Of HN-VAC – Its Cell Culture H1N1 Vaccine
• VaxInnate Licenses Recombinant H1N1 Pandemic Swine Flu Vaccine To Biological E.; Vaccine Could Become Available For Use In India This Year
• SciClone And Sigma-Tau Announce Positive Preliminary Results In Clinical Study Examining ZADAXIN’S Ability To Enhance Response To H1N1 Vaccine
• Canada To Bridge Mexico’s H1N1 Flu Vaccine Requirements
• H1N1 Vaccine Administration Goes Well In Northwest Alabama
• As Influenza Cases Rise In Europe, Experts Urge Uptake Of H1N1 Vaccine
• FDA Approves Additional Vaccine For 2009 H1N1 Influenza Virus
• CSL Biotherapies Obtains FDA Licensure For Use Of Its Thimerosal-Free Pandemic Influenza A (H1N1) 2009 Monovalent Vaccine In Children
• FDA Commissioner Addresses Nation’s Healthcare Professionals On H1N1 Vaccine
• US H1N1 Swine Flu Vaccine Supply On Track To Hit 10 Million Increase Says CDC Director
• Potential Allergen In H1N1 Swine Flu Vaccine May Put Children At Risk-Only Phadia Reveals Both Presence And Severity Of The Allergy
• Get Smart About Swine Flu H1N1 Swine Flu Vaccine Influenza P
• Health Canada Approves Pandemic H1N1 Flu Vaccine For Canadians

Tags: cent, countries, efficacy, give, h1n1, poor, producers, urges, vaccine

This entry was posted on Thursday, May 21st, 2009 at 2:05 am and is filed under Uncategorized. You can follow any responses to this entry through the RSS 2.0 feed. Both comments and pings are currently closed.